BSE filing, NSE: GPTHEALTH. Summary written from the filing by ALFA Finder's alert engine.
GPT Healthcare Ltd: key numbers
- Share price
- ₹132.68
- Market cap
- ₹1,089 Cr
- Revenue (annual)
- ₹472.6 Cr
- Net profit (annual)
- ₹42.22 Cr
- P/E (TTM)
- 23.0×Sector 52.8×
- Promoter holding
- 65.57%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GPT Healthcare Ltd
All →GPT Healthcare Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
GPT Healthcare Annual General Meeting
GPT Healthcare Limited held its 37th Annual General Meeting on August 6, 2026. Shareholders transacted ordinary and special business items as stated in the notice.
GPT Healthcare Earnings Call Transcript: Key Takeaways
GPT Healthcare shows strong 18.2% revenue growth and 66% PAT growth, but struggles with utilization outside its core Kolkata market.
GPT Healthcare Results Update
GPT Healthcare reported Q1 FY27 financial results. Total income grew 18% year-over-year to ₹128.2 Crore, reflecting steady operational performance.
GPT Healthcare Investor Presentation: Key Takeaways
GPT Healthcare reported Q1FY27 revenue of ₹126.2 Cr, up 17.8% YoY, with EBITDA margins improving to 20.4%. The company is executing a proximity-based model in Eastern India.
GPT Healthcare Q1 FY27 Results: Net Profit ₹12.7 Cr, Up 64.9% YoY
GPT Healthcare Ltd reported revenue from operations of ₹126.2 Cr (+17.8% YoY) and net profit of ₹12.7 Cr (+64.9% YoY) for Q1 FY27.
- Key figure
- Net profit ₹12.7 Cr · +64.9% YoY
Other board meeting date announcements
All →Novartis India Board Meeting Date
Evonile Pharma will hold a board meeting on November 4, 2026 to approve the rights issue letter of offer. BSE granted in-principle approval for the rights issue.
CHD Chemicals Board Meeting Date
CHD Chemicals intimated a board meeting on 04 Nov 2026 to consider unaudited half-yearly results for September 2026. Trading window remains closed until 06 Nov 2026.
Max Estates Board Meeting Date
Max Estates Limited has informed exchanges that its board will meet on 4 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 6 November 2026.
GKP Printing & Packaging Board Meeting Date
G.K.P. Printing & Packaging announced a board meeting on 4 November 2026 to approve unaudited results for the quarter ended 30 September 2026. Trading window has been closed for insiders since 1 October 2026.
ADF Foods Board Meeting Date
ADF Foods will hold a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The meeting will also consider an interim dividend for FY2026-27.
MKP Mobility Board Meeting Date
MKP Mobility will hold a board meeting on November 6, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results.